Market Closed - Nasdaq Copenhagen 08:50:00 15/07/2024 pm IST 5-day change 1st Jan Change
135.1 DKK -2.74% Intraday chart for Ambu A/S +0.37% +28.42%

This article is for Premium subscribers only

Signed up already?

Log In

Not subscribed yet?

Subscribe

The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.
Surperformance is Buy on AMBU A/S since 24/06/2024 .

European shares rise ahead of crucial US inflation data RE
Ambu A/S(CPSE:AMBU B) dropped from OMX Copenhagen 20 Index CI
Nordic Shares Moved Upward Wednesday; BioArctic Series B Topped Leaders DJ
Transcript : Ambu A/S, Q2 2024 Earnings Call, May 14, 2024
Ambu A/S Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024 CI
Nordic Stocks Rose Friday; BioArctic Series B Climbed Highest DJ
U.S. Futures Down, European Stocks Mixed DJ
Ambu A/S Revises Revenue Guidance for the Fiscal Year 2023/24 CI
Nordic Stocks Decreased Tuesday; Borr Drilling Took Biggest Hit DJ
Transcript : Ambu A/S, Q1 2024 Earnings Call, Jan 30, 2024
Ambu A/S Reports Earnings Results for the First Quarter Ended December 31, 2023 CI
Ambu A/S Maintains Earnings Guidance for the Full-Year 2023/24 CI
Ambu A/S Appoints Rummana Hasan as Chief Marketing Officer, Effective February 1, 2024 CI
Nordic Stocks Moved Upward Friday; Frontline Topped Leaders DJ
US Futures Mixed, European Stocks Climb DJ
Nordic Shares Rose Wednesday; Hagar Hf. Topped Leaders DJ
Ambu A/S Elects Shacey Petrovic as Vice Chair of Board of Directors CI
Transcript : Ambu A/S - Shareholder/Analyst Call
Simon Barnard: A long-term vision at Smithson Our Logo
Ambu A/S Announces Henrik Ehlers Wulff Not to Run for Re-Election for Board of Directors CI
Nordic Stocks Moved Upward Wednesday; Vestas Wind Systems Topped Leaders DJ
Transcript : Ambu A/S, Q4 2023 Earnings Call, Nov 08, 2023
Ambu A/S Provides Earnings Guidance for the Full-Year 2023/24 CI
Ambu A/S Reports Earnings Results for the Full Year Ended September 30, 2023 CI
Nordic Shares Moved Upward Wednesday; Novo Nordisk Series B Climbed Highest DJ
Chart Ambu A/S
More charts
Ambu A/S is specialized in the design, production and marketing of medical supplies. Net sales break down by family of products as follows: - single-use endoscopes (56.3%); - emergency care and resuscitation devices (22.9%): mechanical ventilation devices (insufflators, laryngeal masks, facial masks and respiratory bags), secretion aspirators, immobilization devices, etc. In addition, the group sells dummies for first aid training centers; - monitoring and diagnostic devices (20.8%): including electrodes used in the fields of cardiology, neurophysiology and first aid. At the end of September 2023, Ambu A/S had four production sites located in China, Malaysia, the United States and Mexico. Net sales are distributed geographically as follows: Denmark (1.2%), Europe (37.8%), the United States (49.5%), North America (1.3%) and other (10.2%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
135.1 DKK
Average target price
117 DKK
Spread / Average Target
-13.40%
Consensus
  1. Stock Market
  2. Equities
  3. AMBU B Stock
  4. News Ambu A/S
  5. Ambu A/S: An innovative leader in single-use medical equipment